Methods
Analytic procedures. The methods for the determination of urinary 5-hydroxyindoleacetic acid (5HIAA), total indole-3-acetic acid (IAA), indican (Ind), kynurenine (Kyn), kynurenic acid (KA), and xanthurenic acid (XA) have been previously described (14) (15) (16) (17) (18) . A Zeiss M4011 spectrophotometer with a fluorimetric attachment using filter E was used for the quantitative fluorescent determinations of XA and KA. The urinary metabolites were further identified by two-dimensional paper chromatography according to Jepson (19) , after which Erhlich's acidic p-dimethylaminobenzaldehyde in acetone was used to identify IAA, Ind, and 5HIAA; XA, KA, and Kyn were identified by their characteristic fluorescence under ultraviolet light. KA and Kyn were further identified by Ninhydrin-pyridine and XA by the sulfanilic acid reagent (19) . From these studies, we were certain that the metabolites determined were actually present in the samples and that other substances that might give a specious color response were not present.
The above determinations were done on three consecutive 8-hour collections of urine for the following 24-hour periods: control, after loading with 4.0 g L-tryptophan in orange juice, and after reloading with 4.0 g L-tryptophan plus 180 mg vitamin B, intramuscularly (90 mg im on 2 consecutive days). A repeat tryptophan load was performed on 2 untreated celiacs at the end of 1 week of oral tetracycline therapy (500 mg four times daily) to determine the effect of partial gut sterilization on the excretion of these metabolites.
Subjects. The study group consisted of 10 normal subjects and 21 patients with adult celiac disease; 5 of these patients were untreated, and 16 were studied on a gluten-free diet. All of the latter were in clinical remission, but only 3 had normal fat excretion at the time of the study.
The diagnosis of adult celiac disease was established in 17 patients with steatorrhea by the characteristic jejunal biopsies ("subtotal" villous atrophy), together with diminished D-xylose absorption, abnormal small bowel series, and salutary response to the gluten-free diet. Four patients who were not biopsied satisfied all of the other criteria. All studies were done on a metabolic ward. urine collections. During these periods bananas, tomatoes, avocados, eggplant, and prunes were excluded from their diets (20) . All medications were withheld 48 hours before collection of specimens of urine and during the study period (21) . The patients who were already on gluten-free diets continued their diets during the study.
Mean and standard deviation of the mean were calculated by standard statistical formulas. Statistical evaluation by means of a t test was made by comparing the levels of excretion of tryptophan metabolites of the normal subjects with those of the patient groups during the first 8 hours of excretion. Probabilities less than 0.05 were considered to indicate a statistically significant difference.
Results
The mean ± SD, expressed in milligrams for each consecutive 8-hour excretion of Ind, IAA, 5HIAA, Kyn, XA, and KA before and after tryptophan loading, is shown in Tables I to IV for the control subjects and the patients with adult celiac diseases. The patient group is further subdivided into untreated patients (Table II) , patients treated with a gluten-free diet but still excreting excessive fecal fat (Table III) , and treated patients without steatorrhea on the diet (Table IV) . Included in the tables are the mean levels of the various metabolites studied during the control period, after the ingestion of 4 g of L-tryptophan, and after 4 g of L-tryptophan plus 180 mg of vitamin B6 (90 mg intramuscularly on 2 consecutive days).
Since the major changes in the excretion pattern of the various metabolites after the tryptophan load were noted in the first 8-hour collection, all reported results will refer primarily to this period.
Normal subjects and untreated adult celiac patients. The mean excretion during the first 8- The previously reported elevated base-line levels of urinary 5HIAA and IAA and indican in the untreated and treated symptomatic adult celiac patients have been confirmed in these studies (12, 13) . It is of great interest that the patients on the gluten-free diet who are still having steatorrhea continue to excrete these substances abnormally. The increased excretion of IAA and IND is not specific for adult celiac disease, for we as well as others have observed increased levels of these metabolites of tryptophan in a variety of malabsorptive states, both intestinal and pancreatogenous (13) .
The urinary indoxyl derivatives presumably are final excretory products formed in the liver from indole absorbed from the gut (22) . In these patients it probably arises from coexistent alteration in gut bacterial flora and increased intraluminal amounts of protein and peptides containing tryptophan, both from undigested food and from protein weeping into the gut. The complete absence of indoxyl sulfate excretion by suppression of the gut flora by 1 week of tetracycline therapy despite feeding L-tryptophan speaks for alteration of a pathway involving action of bacteria. Of note, the indicanuria returns to its high level a few days after cessation of the antibiotics (Table V) . A change in the bacterial flora seems the most likely mechanism in view of the return to normal levels in patients who are in clinical and biochemical remission on a gluten-free diet and who no longer have stasis or distension.
IAA excretion is clearly elevated in patients with untreated celiac disease as well as the patients on gluten-free diet who still have steatorrhea. Part of this abnormal excretion, like indican, may well be related to abnormal gut flora as evidenced by the decrease in IAA after tetracycline when tryptophan is added. That the IAA did not fall to zero suggests that the metabolism of tryptophan to IAA is not purely dependent on altered bacterial flora but that other pathways are also utilized and is also related to abnormal metabolism of absorbed tryptophan by the tissues (15) .
5HIAA excretion is elevated in patients with adult celiac disease in the untreated and treated states with steatorrhea; these elevated levels return to normal with the clinical and biochemical remission that may follow elimination of gluten. Administration of tetracycline, however, does not affect these increased levels, suggesting that they are not solely dependent on bacterial action. As seen in Tables I and IV , after loading with 4 g of L-tryptophan, both the normal subjects and the adult celiac patients on a gluten-free diet without steatorrhea show a similar increase in 5HIAA excretion (p >0.25). However, there is a significant increase in the excretion of 5HIAA after tryptophan loading in the untreated celiac patients and the treated patients with steatorrhea (0.005> p >0.001) (Tables I and III Vitamin B6 is required for the enzymatic conversion of 5-hydroxytryptophan to 5-hydroxytryptamine (serotonin) by 5-hydroxytryptophan decarboxylase (Figure -1) . In view of this requirement, one would expect a lowered base-line excretion of 5-hydroxyindoleacetic acid in Bedeficient subjects (24) . Our studies demonstrate an increased excretion of 5HIAA in the untreated and treated celiac patients with steatorrhea, which is further increased by the oral ingestion of L-tryptophan. When im B6 is given with a repeat tryptophan load to the same group of patients, there is a significant increase in the excretion of 5HIAA. These findings suggest that if these patients did not have a B6 deficiency, the base-line 5HIAA excretion might have been greater.
Under normal circumstances, kynuren'ine and hydroxykynurenine are cleaved by the enzyme kynureninase to alanine plus anthranilic or 3-hydroxyanthranilic acid, respectively (Figure 1 ). Because pyridoxal phosphate (B6) is required for action of this enzyme, the metabolism of both kynurenine and hydroxykynurenine is altered in pyridoxine deficiency. These compounds appear to be shunted through the kynurenine transaminase pathway with the formation of the corresponding alpha-keto acids. These cyclize spontaneously to kynurenic acid and xanthurenic acid, as is evidenced by the finding in the urine of pyridoxine-deficient animals of large amounts of Kyn, KA, and XA, as well as other tryptophan metabolites (25) .
The results obtained in these studies indicate that patients with adult celiac disease, whether treated or not, fail to metabolize an oral L-tryptophan load normally. This metabolic failure is characterized by increased excretion of Kyn, XA, and KA, findings that might be expected in animals and human subjects with a deficiency of B6. This viewpoint is further strengthened by the return to near normal levels of these urinary metabolites after large doses of im B6 are administered simultaneously with the repeat tryptophan load.
The question arises as to the mechanism responsible for the deranged tryptophan metabolism in adult celiac disease. The calculated value of daily intake of B6 in the subjects under study is approximately 2.5 mg (26) , whereas the daily re- Failure of B6 to be incorporated in the enzyme systems required for normal tryptophan metabolism may contribute to its abnormal metabolism. However, when pyridoxine was administered intramuscularly to our patients, biochemical response to tryptophan loading was normal, indicating that availability of B6 was the limiting factor for normal tryptophan metabolism in the patients with adult celiac disease.
All of the celiac patients in the untreated group, as well as some of the patients on the gluten-free diet who were still having steatorrhea, demonstrated superficial scaling of the skin and lesions around the eyes and mouth, with fissures at the angles of the mouth, lateral canthi of the eyes, and sore, reddened tongues. These findings can be seen in vitamin B6 deficiency but are also present as manifestations of other B complex deficiencies (29) . Dramatic relief of these symptoms was obtained in many of these patients after administration of vitamin B6 parenterally during the repeat tryptophan load and orally (10 mg daily) for a few weeks thereafter. Many Regardless of the mechanism of the abnormal response of these patients to a tryptophan load, it would appear justifiable to suggest that they be treated with B6 in addition to the gluten-free diet. Furthermore, Fletcher and McCririck (34) have raised the interesting question whether the glutenfree diet prescribed for patients with adult celiac disease may not be lacking, especially if intake of milk is inadequate, in essential nutrients such as members of the B complex family.
Summary
The excretion of the metabolites of tryptophan -5-hydroxyindoleacetic acid, indole-3-acetic acid, indican, kynurenine, xanthurenic acid, and kynurenic acid-was quantitatively determined in 10 normal subjects and in 21 patients wtih adult celiac disease. Five of the latter group were untreated, and 16 were studied on a gluten-free diet. The determinations were done on three consecutive 8-hour collections of urine for the following 24-hour periods: control, after loading with 4 g L-tryptophan, and after reloading with 4 g L-tryptophan plus 180 mg vitamin B6 intramuscularly (90 mg im on 2 consecutive days).
Elevated urinary levels of 5-hydroxyindoleacetic acid, indole-3-acetic acid, and indican were found in the untreated and treated celiac patients with steatorrhea, whereas normal levels of these metabolites were obtained in the treated patients 0. D. KOWLESSAR, L. J. HAEFFNER, AND G. D. BENSON without steatorrhea. Furthermore, after loading with L-tryptophan the untreated and treated patients with steatorrhea showed a significant increase in their 5-hydroxyindoleacetic acid excretion, suggesting that this group of patients has an augmented shunt of the serotonin to 5-hydroxyindoleacetic acid pathway.
Tetracycline eliminated the elevated levels of indican excretion in 2 untreated patients with celiac disease, even after the tryptophan load, suggesting that these elevated levels were due to the increased breakdown of tryptophan by gut bacteria.
Patients with adult celiac disease regardless of the stage of their disease fail to metabolize an oral tryptophan load normally. This metabolic failure is characterized by significant increases in the excretion of kynurenine, xanthurenic acid, and kynurenic acid, findings seen in human subjects with a deficiency of vitamin B6. This is the first clear-cut evidence for B6 deficiency in adult celiac disease, and our results suggest that these patients should be given supplementary vitamin B6.
